Polomar Health Services reported a gross margin of 61.22% and a net margin of 7.29% for the quarter ended Jun 2026. These financial ratios cover 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 100.00% | 100.00% | 92.85% | 87.14% | 19.93% | 70.76% | 90.00% | 43.46% | 70.06% | 70.05% | 70.14% | 71.00% | 54.75% | 61.22% | ||
| EBT Margin | -298.67% | -506.59% | -802.36% | -332.87% | -1,179.04% | -1,315.92% | -2,754.93% | -3,444.13% | -10,058.45% | -11,070.62% | -10,543.16% | -1,422.17% | -2.52% | 13.11% | ||
| EBIT Margin | -298.67% | -506.59% | -627.66% | -546.84% | -1,179.04% | -1,315.92% | -2,631.47% | -3,301.93% | -9,145.93% | -10,298.59% | -10,202.95% | -1,414.86% | -0.69% | 14.29% | ||
| EBITDA Margin | -298.67% | -506.59% | -627.66% | -546.84% | -1,179.04% | -1,315.92% | -2,631.47% | -3,301.93% | -9,145.93% | -10,298.59% | -10,202.95% | -1,414.86% | -0.69% | 14.29% | ||
| Operating Margin | -298.67% | -506.59% | -627.66% | -546.84% | -1,179.04% | -1,315.92% | -2,631.47% | -3,301.93% | -9,145.93% | -10,298.59% | -10,202.95% | -1,414.86% | -0.69% | 14.29% | ||
| Net Margin | -298.67% | -506.59% | -802.36% | -332.87% | -1,179.04% | -1,315.92% | -2,754.93% | -3,444.13% | -10,058.45% | -11,070.62% | -10,543.16% | -1,422.17% | -2.52% | 7.29% | ||
| FCF Margin | -288.82% | -52.04% | -697.87% | -1,273.23% | -1,515.22% | -1,977.80% | -3,074.24% | -1,509.32% | -1,003.46% | -3,432.91% | -5,722.20% | 30.06% | 3.42% | 7.94% | ||
| Efficiency | ||||||||||||||||
| Inventory AverageInventory Avg. | 0.10M | 0.07M | 0.07M | 0.12M | 0.13M | 0.15M | 0.15M | |||||||||
| Assets AverageAssets Avg. | 0.13M | 0.12M | 0.05M | 269.00 | 5.15M | 10.12M | 9.88M | 9.62M | 9.35M | 4.83M | 0.45M | 0.67M | ||||
| Invested CapitalInvested Cap. | 0.26M | 0.09M | 0.02M | 0.02M | -0.15M | 9.39M | 9.74M | 9.44M | 9.80M | 8.76M | -0.26M | -0.26M | -0.26M | |||
| Asset Utilization RatioAsset Util. | 0.62 | 1.53 | 248.51 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.13 | 3.64 | 4.77 | |||||
| Leverage & Solvency | ||||||||||||||||
| Interest Coverage RatioInterest Cover | -3.59 | 2.56 | -21.31 | -23.22 | -10.02 | -13.34 | -29.99 | -193.57 | -0.37 | 12.12 | ||||||
| Debt Ratio | 0.27 | 0.05 | 0.04 | 0.61 | 217.73 | 0.01 | 0.11 | 0.13 | 0.15 | 0.11 | 2.46 | 1.91 | 0.98 | |||
| Times Interest Earned | -3.59 | 2.56 | -21.31 | -23.22 | -10.02 | -13.34 | -29.99 | -193.57 | -0.37 | 12.12 | ||||||
| Valuation | ||||||||||||||||
| Price to EarningsP/E | -279.58 | -0.04M | -0.01M | -0.00M | -843.12 | -305.91 | -0.00M | -846.82 | -137.60 | -2.69 | -23.61 | -19.38 | -8.62 | -2.49 | -176.87 | 30.44 |
| Price to SalesP/S | 835.05 | 0.19M | 0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 92.77 | 0.00M | 0.00M | 909.29 | 35.46 | 4.46 | 2.22 | ||
| Price to BookP/B | -58.10 | 0.03M | 0.01M | 0.00M | 0.01M | -395.28 | -798.56 | -408.15 | 4.01 | 0.23 | 1.32 | 1.40 | 0.72 | -18.34 | -3.60 | -3.21 |
| Enterprise Value | 3.77M | 5,837.58M | 1,074.13M | 386.46M | 145.12M | 17.60M | 163.68M | 161.50M | 37.32M | 1.93M | 10.66M | 11.73M | 5.57M | 22.28M | 4.40M | 3.21M |
| EV to EBIT | -279.24 | -0.04M | -0.01M | -0.00M | -0.00M | -186.12 | -0.00M | -846.72 | -143.99 | -2.80 | -25.65 | -20.83 | -8.85 | -2.49 | -637.59 | 14.72 |
| EV to EBITDA | -279.24 | -0.04M | -0.01M | -0.00M | -0.00M | -186.12 | -0.00M | -846.72 | -143.99 | -2.80 | -25.65 | -20.83 | -8.85 | -2.49 | -637.59 | 14.72 |
| Market Capitalization | 3.78M | 5,837.80M | 1,074.33M | 386.49M | 145.15M | 17.60M | 163.71M | 161.52M | 37.34M | 1.94M | 10.79M | 11.74M | 5.60M | 22.42M | 4.49M | 3.39M |
| Price to FCFP/FCF | -289.12 | -0.37M | -0.01M | -0.00M | -969.36 | -79.98 | -793.84 | -563.43 | -123.31 | -6.15 | -236.67 | -62.50 | -15.89 | 117.96 | 130.57 | 27.98 |
| EV to FCF | -288.77 | -0.37M | -0.01M | -0.00M | -969.11 | -79.94 | -793.71 | -563.36 | -123.25 | -6.13 | -233.83 | -62.48 | -15.78 | 117.27 | 128.02 | 26.50 |
| EV to CFO | -288.77 | -0.37M | -0.01M | -0.00M | -969.11 | -79.94 | -993.42 | -651.47 | -127.75 | -6.13 | -233.83 | -62.48 | -15.78 | 117.27 | 128.02 | 26.50 |
| Return Ratios | ||||||||||||||||
| Return on Sales [ROS]ROS | -298.67% | -506.59% | -627.66% | -546.84% | -1,179.04% | -1,315.92% | -2,631.47% | -3,301.93% | -9,145.93% | -10,298.59% | -10,202.95% | -1,414.86% | -0.69% | 14.29% | ||
| Return on Capital Employed [ROCE]ROCE | -407.57% | -2,631.87% | 1,649.67% | 565.14% | -16.81% | -14.79% | -18.91% | -22.45% | -29.26% | -327.90% | 774.89% | |||||
| Return on Assets [ROA]ROA | -389.60% | -347.76% | -896.45% | -215,955.39% | -13.21% | -13.25% | -16.58% | -21.33% | -26.00% | -221.56% | -2,265.42% | -1,421.70% |